Stocktoria

Anika Therapeutics, Inc. ANIK

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1985-05-16 · LEI

Anika Therapeutics, Inc. statistics & valuation

Market cap$200.9M
P / S1.8×
P / B1.4×
P / FCF46.1×
Net margin-9.6%
Return on equity-7.6%
FCF margin3.9%
Return on capital-6.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
31.50% 28.10% 17.70% 23.70% -18.40% 2.80% -13.10% -68.40% -47.00% -9.60% 2016201720182019202020212022202320242025
Gross margin (%)
70.40% 74.90% 52.90% 56.10% 64.30% 68.30% 63.40% 56.60% 2016201720182019202020212022202320242025
Operating margin (%)
49.00% 40.30% 20.60% 29.90% -21.70% 1.80% 3.20% 0.70% -4.30% -9.80% 2016201720182019202020212022202320242025
Return on equity (%)
14.60% 12.10% 7.10% 9.40% -8.80% 1.40% -5.20% -38.90% -36.60% -7.60% 2016201720182019202020212022202320242025
Shares outstanding
15.1M 15.1M 14.7M 14.4M 14.3M 14.6M 14.8M 14.7M 14.7M 14.3M 2016201720182019202020212022202320242025
Net debt ($)
-$157.5M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
13.50% 11.30% 6.70% 8.20% -6.60% 1.20% -4.30% -30.50% -27.80% -5.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
10.10% 28.10% 28.70% 29.80% 8.80% 2.20% -2.70% -6.00% -1.90% 3.90% 2016201720182019202020212022202320242025
Debt / equity (×)
0.00× 2016201720182019202020212022202320242025
EPS ($)
$2.15 $2.11 $1.27 $1.89 -$1.69 $0.28 -$1.02 -$5.64 -$3.83 -$0.76 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Anika Therapeutics, Inc. trades at about 78.7× earnings — above its 10-year norm (10-year range 13×–113.6×, median 23.5×).

13× 113.6×

Shaded band = 10-year range (13×–113.6×); dot = today's 78.7×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin56.6%63.4%68.3%64.3%56.1%52.9%74.9%70.4%——
Operating margin-9.8%-4.3%0.7%3.2%1.8%-21.7%29.9%20.6%40.3%49.0%
Net margin-9.6%-47.0%-68.4%-13.1%2.8%-18.4%23.7%17.7%28.1%31.5%
FCF margin3.9%-1.9%-6.0%-2.7%2.2%8.8%29.8%28.7%28.1%10.1%
Return on assets-5.7%-27.8%-30.5%-4.3%1.2%-6.6%8.2%6.7%11.3%13.5%
Return on equity-7.6%-36.6%-38.9%-5.2%1.4%-8.8%9.4%7.1%12.1%14.6%
Debt / equity——————0.00×———
Current ratio4.724.885.266.075.664.8114.3917.9815.7819.37

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.